GSK plc (GSK) Form 6-K — Sep 9, 2026
GSK plc filed a Form 6-K on September 9, 2026 containing regulatory transaction notifications for two persons discharging managerial responsibilities, with transactions dated September 8, 2026. SVP & Company Secretary Victoria Whyte and Neil Falkingham, a person closely associated with GSK President, Europe Lynn Baxter, were each awarded 10,050 ordinary shares at £17.9650 per share under the company's 2025 Share Value Plan.
Key figures
- Plan name
- 2025 Share Value Plan
- Instrument isin
- GB00BN7SWP63
- Transaction date
- 2026-09-08
- Award price gbp per share
- 17.965
- Shares awarded per person
- 10050
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.